TUBA1B and cancer: Subsequently, we analyzed the effect of TUBA1B methylation levels on the prognosis of cancer patients, including DSS, OS, and PFS, and the results showed that the low methylation status of TUBA1B was a risk factor for patients with LGG and LIHC, but a protective factor for patients with UCEC (Fig. S4E).